pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Alzheimer's Disease · news · pharmadog
← back to Alzheimer's Disease
News mentioning Alzheimer's Disease
11
stories
10d
Acadia misses mark in Alzheimer’s but concludes phase 3 ‘absolutely worth’ pursuing
fiercebiotech
Aug 25, 26
Roche, Eli Lilly get FDA nod for new Alzheimer’s blood test
biopharma dive
Aug 24, 26
Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood test
fiercebiotech
Aug 17, 26
FDA clears Lantheus’ Alzheimer’s PET imaging agent Tauklarify
fiercebiotech
Aug 14, 26
MapLight dims preclinical programs to make phase 3-ready schizophrenia drug shine brighter
fiercebiotech
Aug 11, 26
CytoDyn’s leronlimab reaffirms HIV potential after combo treatment eradicates virus in infant macaques
fiercebiotech
Aug 6, 26
Chutes & Ladders—BioNTech brings in Sobi CEO
fiercebiotech
Jul 27, 26
MapLight dives despite positive data for schizophrenia drug
biopharma dive
Jul 14, 26
Biogen's tau drug reports mixed Alzheimer's results, as low dose performs better
endpoints
Jul 14, 26
Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugs
biopharma dive
Dec 23, 25
Fierce Biotech Layoff Tracker 2026: Foghorn cuts workforce by 40%; BioMarin drops 117 roles
fiercebiotech
